Orodispersible Films as a Solution to Drug Acceptability Issues: A Short Review

Main Article Content

Mohamed Yafout
Hicham Elhorr
Amine Ousaid
Ibrahim Sbai El Otmani
Youssef Khayati


Despite the fact that the tablets are the most widely used dosage form, they are not suitable for young children and patients with swallowing difficulties, especially the elderly. Orodispersible films (ODFs) dissolve rapidly in the mouth and deliver an accurate amount of the active ingredient, which makes them an easy-to-use dosage form that can improve drug acceptability and, therefore, treatment adherence. The findings of the 4 studies that we discussed in this review prove that ODFs have experimentally-proven good acceptability in all age groups and that they are clinically superior to tablets and syrups in terms of acceptability. Therefore, despite some limitations, ODFs are still an innovative and patient-centered dosage form that can contribute to improving drug acceptability and treatment adherence particularly in children and elderly patients. Pharmaceutical companies should focus on developing more ODF-based drugs and also other innovative dosage forms that can make the drug-taking experience even-easier. 

Orodispersible films, drug acceptability, treatment adherence, pediatric patients, geriatric patients, innovative dosage forms, swallowing difficulty

Article Details

How to Cite
Yafout, M., Elhorr, H., Ousaid, A., Otmani, I. S. E., & Khayati, Y. (2021). Orodispersible Films as a Solution to Drug Acceptability Issues: A Short Review. Asian Journal of Research in Medical and Pharmaceutical Sciences, 10(2), 36-41. https://doi.org/10.9734/ajrimps/2021/v10i230161
Review Article


European Medicine Agency 2013. Guideline on pharmaceutical development of medicines for paediatric use EMA/CHMP/QWP/805880/2012.
Available:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2013/07/WC500147002.pdf
(Accessed 20th February 2021)

Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R, Tuleu C. Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients. Adv Drug Deliv Rev 2014;73:14–33.

Liu F, Ranmal S, Batchelor HK, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: Similarities and differences in paediatric and geriatric populations. Drugs. 2014;74: 1871-89.

Sunakawa K, Akita H, Iwata S, et al. Rational use of oral antibiotics for pediatric infections. Infection 1995;23(Suppl 2): S74–8.

Dagan R, Shvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J. 1994;13: 686–90.

European Medicine Agency 2020. Reflection paper on the pharmaceutical development of medicines for use in the older population. EMA/CHMP/QWP/ 292439/2017.
(Accessed 20th February 2021)

Helliwell M, Taylor D. Solid oral dosage forms. Prof Nurse. 1993;8(5):313-7

Walsh J, Ranmal SR, Ernest TB, Liu F. Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations. Int J Pharm. 2018;536(2):547-62

Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: Prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937- 48.

European Pharmacopoeia 10th Edition. European Directorate for the Quality of Medicines & Healthcare (EDQM); Released July 2019.

United States Pharmacopeia and National Formulary (USP 41-NF 36). United States Pharmacopeial Convention; Released November 2017.

Hanning SM, Lopez FL, Wong ICK, Ernest TB, Tuleu C, Orlu Gul M. Patient centric formulations for paediatrics and geriatrics: Similarities and differences. Int J Pharm. 2016;512(2):355-9.

Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67-76.

Cilurzo F, Musazzi UM, Franzé S, Selmin F, Minghetti P. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements. Drug Discov Today. 2018;23(2):251-9.

Orlu M, Ranmal SR, Sheng Y, Tuleu C, Seddon P. Acceptability of orodispersible films for delivery of medicines to infants and preschool children. Drug Deliv. 2017; 24(1):1243-1248.

Abdelhakim HE, Williams GR, Craig DQM, Orlu M, Tuleu C. Human mouthfeel panel investigating the acceptability of electrospun and solvent cast orodispersible films. Int J Pharm. 2020; 585:119532.

Klingmann V, Pohly CE, Meissner T, et al. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial. Eur J Pharm Biopharm. 2020;151: 239-45.

Nishigaki M, Kawahara K, Nawa M, et al. Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: clinical usefulness. Int J Pharm. 2012;424(1-2): 12-17.

Scarpa M, Stegemann S, Hsiao WK, et al. Orodispersible films: Towards drug delivery in special populations. Int J Pharm. 2017;523(1):327-335.

Gupta MS, Kumar TP, Gowda DV. Orodispersible Thin Film: A new patient-centered innovation. J Drug Deliv Sci Technol. 2020;59:101843.

Yir-Erong B, Bayor MT, Ayensu I, Gbedema SY, Boateng JS. Oral thin films as a remedy for noncompliance in pediatric and geriatric patients. Therapeutic Delivery; 2019.

Visser JC, Wibier L, Mekhaeil M, et al. Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study. Int J Clin Pharm. 2020;42:436-44.